Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing
Authors
Keywords
-
Journal
Genome Medicine
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-03-04
DOI
10.1186/s13073-023-01164-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
- (2022) Ruidong Xue et al. NATURE
- Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes
- (2021) Ruli Gao et al. NATURE BIOTECHNOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
- (2021) Kevin Bi et al. CANCER CELL
- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
- (2021) Sijin Cheng et al. CELL
- Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
- (2021) Yang Liu et al. Nature Communications
- Twelve years of SAMtools and BCFtools
- (2021) Petr Danecek et al. GigaScience
- Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
- (2021) Chang Cui et al. CELL
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
- (2021) Ayse Bassez et al. NATURE MEDICINE
- Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
- (2021) Justina X. Caushi et al. NATURE
- Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
- (2021) Giacomo Oliveira et al. NATURE
- Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
- (2021) Can Cui et al. CELL
- Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial
- (2020) Julien Mazieres et al. CLINICAL CANCER RESEARCH
- IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY
- (2020) William D. Travis et al. Journal of Thoracic Oncology
- Peripheral T cell expansion predicts tumour infiltration and clinical response
- (2020) Thomas D. Wu et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
- (2020) Mirjana Efremova et al. Nature Protocols
- Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
- (2020) Yiwen Lu et al. CELL
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
- (2020) Lei Zhang et al. CELL
- A conserved dendritic-cell regulatory program limits antitumour immunity
- (2020) Barbara Maier et al. NATURE
- Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
- (2020) Kurt A. Schalper et al. NATURE MEDICINE
- Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms
- (2020) Alexander J Neuwelt et al. Journal for ImmunoTherapy of Cancer
- Generalizing RNA velocity to transient cell states through dynamical modeling
- (2020) Volker Bergen et al. NATURE BIOTECHNOLOGY
- Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
- (2020) Mariano Provencio et al. LANCET ONCOLOGY
- Efficacy and safety of neoadjuvant immunotherapy in resectable nonsmall cell lung cancer: A meta-analysis
- (2020) Xiao-hui Jia et al. LUNG CANCER
- Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils
- (2020) Michela Perego et al. Science Translational Medicine
- Tumor-Infiltrating Natural Killer Cells
- (2020) Beatriz Cózar et al. Cancer Discovery
- Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
- (2019) Dvir Aran et al. NATURE IMMUNOLOGY
- CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3
- (2019) Ines Block et al. ONCOGENE
- Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
- (2019) Xindong Liu et al. NATURE
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data
- (2019) Samuel L. Wolock et al. Cell Systems
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- The estrogen pathway as a modulator of response to immunotherapy
- (2019) Maria A Velez et al. Immunotherapy
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
- (2019) Antoinette van Weverwijk et al. Nature Communications
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
- (2019) David Liu et al. NATURE MEDICINE
- Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
- (2019) Sangeeta Goswami et al. NATURE MEDICINE
- NicheNet: modeling intercellular communication by linking ligands to target genes
- (2019) Robin Browaeys et al. NATURE METHODS
- IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma
- (2018) Bowie Y. Cheng et al. CANCER RESEARCH
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer
- (2018) Edward B. Garon et al. LUNG CANCER
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
- (2018) Xinyi Guo et al. NATURE MEDICINE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- S100A8/A9 in Inflammation
- (2018) Siwen Wang et al. Frontiers in Immunology
- RNA velocity of single cells
- (2018) Gioele La Manno et al. NATURE
- Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection
- (2018) Benoit Allard et al. Frontiers in Immunology
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- Biological Consequences of Major Histocompatibility Class-II Expression by Tumor Cells in Cancer
- (2018) Margaret L Axelrod et al. CLINICAL CANCER RESEARCH
- Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma
- (2017) Yan Zhang et al. EXPERIMENTAL CELL RESEARCH
- Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways
- (2017) Cheng-Hsun Lu et al. INFLAMMATION
- AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
- (2017) Xuebiao Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
- (2017) Nathaniel R West et al. NATURE MEDICINE
- SCENIC: single-cell regulatory network inference and clustering
- (2017) Sara Aibar et al. NATURE METHODS
- Single-cell mRNA quantification and differential analysis with Census
- (2017) Xiaojie Qiu et al. NATURE METHODS
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Neutrophils dominate the immune cell composition in non-small cell lung cancer
- (2017) Julia Kargl et al. Nature Communications
- FcRL4 Expression Identifies a Pro-inflammatory B Cell Subset in Viremic HIV-Infected Subjects
- (2017) Basile Siewe et al. Frontiers in Immunology
- Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
- (2016) Douglas B. Johnson et al. Nature Communications
- Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
- (2016) Nikolaos Svoronos et al. Cancer Discovery
- CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
- (2015) S. Svensson et al. CLINICAL CANCER RESEARCH
- Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage
- (2015) Caitlyn W. Barrett et al. JOURNAL OF CLINICAL INVESTIGATION
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Patrolling monocytes control tumor metastasis to the lung
- (2015) R. N. Hanna et al. SCIENCE
- Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis
- (2014) L Yeo et al. ANNALS OF THE RHEUMATIC DISEASES
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Non-small-cell lung cancer
- (2011) Peter Goldstraw et al. LANCET
- Synuclein γ Stimulates Membrane-Initiated Estrogen Signaling by Chaperoning Estrogen Receptor (ER)-α36, a Variant of ER-α
- (2010) Yuenian Eric Shi et al. AMERICAN JOURNAL OF PATHOLOGY
- Human Cytosolic Hydroxysteroid Dehydrogenases of the Aldo-ketoreductase Superfamily Catalyze Reduction of Conjugated Steroids
- (2009) Yi Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started